相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis
Steven R. Ytterberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Risk of herpes zoster (shingles) in patients with rheumatoid arthritis under biologic, targeted synthetic and conventional synthetic DMARD treatment: data from the German RABBIT register
Imke Redeker et al.
ANNALS OF THE RHEUMATIC DISEASES (2022)
Age-based (<65 vs >= 65 years) incidence of infections and serious infections with tofacitinib versus biological DMARDs in rheumatoid arthritis clinical trials and the US Corrona RA registry
Kevin L. Winthrop et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Nonserious Infections in Patients With Rheumatoid Arthritis: Results From the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
Katie Bechman et al.
ARTHRITIS & RHEUMATOLOGY (2021)
Postapproval Comparative Safety Study of Tofacitinib and Biological Disease-Modifying Antirheumatic Drugs: 5-Year Results from a United States-Based Rheumatoid Arthritis Registry
Joel M. Kremer et al.
ACR OPEN RHEUMATOLOGY (2021)
Burden of infections on older patients presenting to general practice: a registry-based study
Thomas Struyf et al.
FAMILY PRACTICE (2021)
Long-term safety of tofacitinib up to 9.5 years: a comprehensive integrated analysis of the rheumatoid arthritis clinical development programme
Stanley B. Cohen et al.
RMD OPEN (2020)
Risk of admission to hospital for serious infection after initiating tofacitinib versus biologic DMARDs in patients with rheumatoid arthritis: a multidatabase cohort study
Ajinkya Pawar et al.
LANCET RHEUMATOLOGY (2020)
Variable selection strategies and its importance in clinical prediction modelling
Mohammad Ziaul Islam Chowdhury et al.
FAMILY MEDICINE AND COMMUNITY HEALTH (2020)
Prediction of infection risk in rheumatoid arthritis patients treated with biologics: are we any closer to risk stratification?
Meghna Jani et al.
CURRENT OPINION IN RHEUMATOLOGY (2019)
Variable selection - A review and recommendations for the practicing statistician
Georg Heinze et al.
BIOMETRICAL JOURNAL (2018)
A pooled analysis of the safety of tofacitinib as monotherapy or in combination with background conventional synthetic disease-modifying antirheumatic drugs in a Phase 3 rheumatoid arthritis population
Alan J. Kivitz et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2018)
Use of a baseline risk score to identify the risk of serious infectious events in patients with rheumatoid arthritis during certolizumab pegol treatment
Jeffrey R. Curtis et al.
ARTHRITIS RESEARCH & THERAPY (2017)
Opioid Analgesics and the Risk of Serious Infections Among Patients With Rheumatoid Arthritis A Self-Controlled Case Series Study
Andrew D. Wiese et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis
Jasvinder A. Singh et al.
LANCET (2015)
Difference in the risk of serious infections in patients with rheumatoid arthritis treated with adalimumab, infliximab and etanercept: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry
Sanne A. A. van Dartel et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment
Joachim Listing et al.
RHEUMATOLOGY (2013)
Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: Comparison of adalimumab, etanercept and infliximab in the GISEA registry
Fabiola Atzeni et al.
AUTOIMMUNITY REVIEWS (2012)
Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)
W. G. Dixon et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Comparison of Drug Retention Rates and Causes of Drug Discontinuation Between Anti-Tumor Necrosis Factor Agents in Rheumatoid Arthritis
Sophie Martin Du Pan et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Frequency of infection in patients with rheumatoid arthritis compared with controls - A population-based study
MF Doran et al.
ARTHRITIS AND RHEUMATISM (2002)
Predictors of infection in rheumatoid arthritis
MF Doran et al.
ARTHRITIS AND RHEUMATISM (2002)
分享论文
